1lrvine WJ,McCallum C J,Gray RS. Clinical and pathogenic significance of panereatie-ialet-cell antibodies in diabetics treated with oral hypoglyeacmic agents[J].The Lancet,1977.1025-1027.
4Gale EA. Latent autoimmune diabetes in adults:a guide for the perplexed[J].Diabetologia,2005.2195-2199.doi:10.1007/s00125-005-1954-5.
5Leslie RD,Kolb H,Sehloot NC. Diabetes classification:grey zones,sound and smoke:action LADA 1[J].Diabetes/Metabolism Research and Review,2008.511-519.doi:10.1002/dmrr.877.
6Li X,Zhou ZG,Huang G. Metabolic syndrome in adultonset latent anteimmune diabetes[J].METABOLIC SYNDROME AND RELATED DISORDERS,2005.174-180.doi:10.1089/met.2005.3.174.
7Hawa MI,Thivolet C,Mauricio D. Metabolic syndrome and autoimmune diabetes:action LADA 3[J].Diabetes Care,2009,(1):160-164.doi:10.2337/dc08-1419.
8Pietropaolo M,Barinas-Mitcbell E,Kuller LH. The heterogeneity of diabetes:unravelling a dispute:is systemic inflammation related to islet autoimmanity?[J].Diabetes,2007,(5):1189-1197.doi:10.2337/db06-0880.
9Lin J,Zhou ZG,Wang JP. From type 1,through LADA,to type 2 diabetes:a continuous spectrum?[J].Annals of the New York Academy of Sciences,2008.99-102.
10Yang ZF,Zhou ZG,Li X. Rosiglitazone preserves islet beta-cell function of adult-onset latent autoimmune diabetes in 3 years follow-up study[J].Diabetes Research and Clinical Practice,2009,(1):54-60.doi:10.1016/j.diabres.2008.09.044.
10Kadiyala R, Peter R, Okosieme OE. Thyroid dysfunction in pa- tients with diabetes:clinical implications and screening strategies [J]. Int J Clin Pract,2010,64(8) :1130-1139.
